Skip to main content

CORRECTION article

Front. Surg., 12 January 2023
Sec. Orthopedic Surgery
Volume 9 - 2022 | https://doi.org/10.3389/fsurg.2022.1122963

Corrigendum: D-lactate is a promising biomarker for the diagnosis of periprosthetic joint infection

This article is a correction to:

  1. D-lactate is a promising biomarker for the diagnosis of periprosthetic joint infection

    1. Read original article
\r\nMichael Fuchs Michael Fuchs1*Martin FaschingbauerMartin Faschingbauer1Maximilian Riklin-DoldMaximilian Riklin-Dold1Paula MorovicPaula Morovic2Heiko ReichelHeiko Reichel1Andrej TrampuzAndrej Trampuz2Svetlana Karbysheva\r\nSvetlana Karbysheva2
  • 1Universitäts- und Rehabilitationskliniken Ulm, Ulm, Germany
  • 2Charité Universitätsmedizin Berlin, Berlin, Baden-Wurttemberg, Germany

A Corrigendum on

D-lactate is a promising biomarker for the diagnosis of periprosthetic joint infection

By Fuchs M, Faschingbauer M, Riklin-Dold M, Morovic P, Reichel H, Trampuz A, Karbysheva S. (2022) Front. Surg. 9:1082591. doi: 10.3389/fsurg.2022.1082591

Incorrect Funding

In the published article, there was an error in the Funding statement. [This work was supported by an educational grant of the PRO-IMPLANT Foundation, Berlin, Germany (https://www.pro-implant.org), a non-profit organization supporting research, education, global networking, and care of patients with bone, joint or implant-associated infection.].

The correct Funding statement appears below.

Funding

[This work was supported by an educational grant of the PRO-IMPLANT Foundation, Berlin, Germany (https://www.pro-implant.org), a non-profit organization supporting research, education, global networking, and care of patients with bone, joint or implant-associated infection. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitaetsmedizin Berlin and the German Research Foundation (DFG).]

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: biomarker, periprosthetic joint infection, D-lactate, septic revision, diagnostic tool

Citation: Fuchs M, Faschingbauer M, Riklin-Dold M, Morovic P, Reichel H, Trampuz A and Karbysheva S (2023) Corrigendum: D-lactate is a promising biomarker for the diagnosis of periprosthetic joint infection. Front. Surg. 9:1122963. doi: 10.3389/fsurg.2022.1122963

Received: 13 December 2022; Accepted: 14 December 2022;
Published: 12 January 2023.

Approved by: Frontiers in Surgery Editorial Office, Frontiers Media SA, Switzerland

© 2023 Fuchs, Faschingbauer, Riklin-Dold, Morovic, Reichel, Trampuz and Karbysheva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michael Fuchs michi.fuchs@mac.com

Specialty Section: This article was submitted to Orthopedic Surgery, a section of the journal Frontiers in Surgery

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.